Stockscreener 앱 받기
0.534
9.49%
-0.056
전일 마감가:
$0.59
열려 있는:
$0.6
하루 거래량:
14.25M
Relative Volume:
1.74
시가총액:
$12.75M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.8476
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
+64.31%
1개월 성능:
-12.32%
6개월 성능:
-81.13%
1년 성능:
-89.21%
1일 변동 폭
$0.51
$0.6288
1주일 범위
$0.376
$0.78
52주 변동 폭
$0.2179
$7.48
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.534 | 12.75M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks
ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire
ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq
Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan
ProPhase Labs hires Stuart Hollenshead as COO - TipRanks
ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire
ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com
ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha
ProPhase Labs appoints Stu Hollenshead as COO - Investing.com
Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan
ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com - Defense World
ProPhase Labs FY2024 EPS Estimate Reduced by Diamond Equity - Defense World
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs Appoints New Chief Operating Officer - TipRanks
ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa
ProPhase Labs appoints new COO amid executive changes - MSN
StockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World
Following A -1.03% Weekly Decline, Is It Still A Buy For ProPhase Labs Inc (NASDAQ: PRPH)? - Marketing Sentinel
ProPhase Labs Inc [PRPH] moved up 1.41: Why It’s Important - The DBT News
PRPH’s Q2 earnings predictions: What the experts say - US Post News
ProPhase Labs Enters into Common Stock Purchase Agreement with Equity Line Investor - Defense World
ProPhase Labs (NASDAQ:PRPH) Coverage Initiated by Analysts at StockNews.com - Defense World
ProPhase Labs stock hits 52-week low at $0.41 amid sharp decline - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
StockNews.com Initiates Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World
ProPhase Labs Announces Closing of $23.6 Million Sale of - GlobeNewswire
An undisclosed buyer acquired Pharmaloz Manufacturing Inc. and Pharmaloz Real Estate Holdings, Inc. from ProPhase Labs, Inc. for approximately $23.6 million. - Marketscreener.com
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles By Investing.com - Investing.com South Africa
ProPhase Labs Closes $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm - citybiz
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm - The Manila Times
ProPhase Labs Sells Manufacturing Units for $23.6M, Eliminates $20M in Debt in Strategic Sale - StockTitan
PRPH (ProPhase Labs) 3-Year Book Growth Rate : 44.30% (As of Sep. 2024) - GuruFocus.com
PRPH (ProPhase Labs) Debt-to-EBITDA : -1.36 (As of Sep. 2024) - GuruFocus.com
ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline - Investing.com Canada
ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that t - Defense World
ProPhase Labs faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
ProPhase Labs faces potential Nasdaq delisting over share price - Investing.com
HighTower Advisors LLC Boosts Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline - Investing.com Australia
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline - Investing.com
ProPhase Labs secures private equity backing, nears lozenge deal, and plans cost-cutting measures - MSN
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures - The Manila Times
ProPhase Labs Secures Global Private Equity Backing, Nears - GlobeNewswire
ProPhase Labs Secures Game-Changing Financing Deal, Eyes Major Asian Market Expansion - StockTitan
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
3.50%
자본화:
|
볼륨(24시간):